BTG3 and systemic lupus erythematosus: Among cases who fulfilled the entry criterion (i.e. serum ANA positivity) and were tested for other autoantibodies and complement (n = 15), the 2019 EULAR/ACR criteria for SLE were met in 14 (93%) patients.